- Home
- PTA vs TNDM Comparison
PTA vs TNDM Comparison
Compare PTA & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTA | TNDM |
|---|---|---|
| Founded | 2020 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | PTA | TNDM |
|---|---|---|
| Price | $19.49 | $20.87 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $22.00 |
| AVG Volume (30 Days) | 159.2K | ★ 2.6M |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | ★ 8.31% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,007,001,000.00 |
| Revenue This Year | N/A | $8.59 |
| Revenue Next Year | N/A | $10.19 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 17.87 |
| 52 Week Low | $15.84 | $9.98 |
| 52 Week High | $19.67 | $38.28 |
Technical Indicators
Market Signals| Indicator | PTA | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 45.91 | 64.34 |
| Support Level | $19.29 | $19.47 |
| Resistance Level | $19.59 | $21.07 |
| Average True Range (ATR) | 0.23 | 1.15 |
| MACD | 0.04 | -0.08 |
| Stochastic Oscillator | 78.29 | 69.86 |
Price Performance
Historical ComparisonAbout PTA Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund of Beneficial Interest
COHEN & STEERS TAX-ADV PRD SEC AND INC is a non-diversified, closed-end management statutory trust. Its primary investment objective is high current income, and the Fund's secondary investment objective is capital appreciation.
About TNDM Tandem Diabetes Care Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.